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F-FDG PET arterial imaging has been shown to be able to image metabolic activity in atherosclerosis in humans, and hence provides a marker of plaque inflammation [1] . It has also been used in several trials of novel antiatherosclerosis therapies as a surrogate marker of treatment efficacy [2, 3] . The FDG uptake in the arterial wall is attributed to its preferential uptake by plaque macrophages over other cells within the vessel wall [4] . Despite increasing acceptance of FDG PET as a marker of vessel wall inflammation, the optimal vascular FDG PET acquisition protocol and image analysis methodologies are still debated [5, 6] . In these protocols, appropriate FDG circulation time (the time between FDG injection and the start of data acquisition), the patient's prescan fasting glucose level, and the minimum FDG dose injected are deemed critical [1, 4, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Optimizing these factors will also help to minimize patient radiation exposure, an important consideration especially when follow-up studies are required as part of drug trials.
Standardization of data analysis is essential to facilitate comparison between different trials [5] . While most previous studies have used the ratio of the target (plaque, arterial wall) to the background (blood; target-to-background ratio, TBR) to quantify plaque FDG uptake, some have used vessel SUV without correction for blood-pool FDG activity [1, 4, 10, 11, 19] .
The aim of this study was to address the impact of the above methodological variables in a large, prospectively imaged study population of patients with established or suspected cardiovascular disease (CVD).
Materials and methods
Study design
The study was conducted at the Mount Sinai School of Medicine, New York, USA. All subjects gave written informed consent. The study was fully approved by our institutional review board. Men and women with a diagnosis of CVD or with multiple CVD risk factors were recruited. The definition of CVD was previous myocardial infarction, stroke, transient ischemic attack, a history of peripheral artery disease, or a history of a coronary revascularization procedure. We deliberately chose a heterogeneous population of patients to study. This allowed us to examine the effect of the methodology on a wide range of SUV values, to ensure maximum applicability to routine practice. None of the subjects was an oncological patient. Patients with a fasting glucose level ≥11.1 mmol/l or previous carotid surgery were excluded from the study.
Questionnaire, biometric and biochemical measurements
We assessed the presence of cardiovascular risk factors, the use of medication, and a family history of CVD using a questionnaire. The presence of hypertension was defined as a history systolic blood pressure >140 mmHg, or a diastolic blood pressure >90 mmHg. Diabetes was defined as a documented diagnosis of type 1 or 2 diabetic disease and the use of antidiabetic treatment (diet, or oral or insulin treatment). Weight and height were measured to calculate the body mass index (BMI). Smoking was defined as smoking at least one cigarette daily. Fasting glucose levels were obtained by finger stick blood glucose measurements (Accu-Chek™ Advantage™; Roche Diagnostics; Indianapolis, IN) prior to FDG administration.
FDG PET/CT imaging FDG PET/CT was performed after an overnight fast using a GE Healthcare (Milwaukee, WI) Lightspeed Discovery™ ST 16-slice PET/CT scanner. FDG was administered intravenously (562.4±92.5 MBq) and patients rested comfortably for approximately 90 to 120 min.
The ascending aorta was imaged first covering the area from the heart to the aortic arch as the upper limit, over 15-30 min (one or two bed positions) acquisition time depending on the patient's anatomy. The patient's head was then placed in a holder for imaging of the carotids. Images from one bed position (15.5 cm) with coverage extending inferior to the internal auditory meatus were acquired for 15 min. We chose two separate acquisitions to provide better image quality, with arms up for the aorta acquisition and arms down for the carotid acquisition.
A low-dose CT scan (140 kV, 80 mA, and 4.25 mm slice thickness) was performed for attenuation correction and coregistration. No CT contrast agent was administered so that those with renal impairment could be imaged. CT contrast agent was also not used for the main studies of reproducibility, but reproducibility was still excellent [20, 21] .
Image analysis of the vessels
Images were analyzed on a dedicated commercially available workstation (Extended Brilliance™ Workspace V4.0.0.3206; Philips Medical Systems Inc., Cleveland, OH). An experienced reader (J.B.) analyzed all scans [19] . Arterial FDG uptake was quantified by manually drawing a region of interest (ROI) around each common carotid artery and the ascending aorta, including the vessel lumen, on every slice of coregistered transaxial PET/CT images. Next, the maximum arterial standardized uptake value (SUV; highest pixel activity within the ROI) was determined. The SUV is the decay-corrected tissue concentration of FDG in kilobecquerels per milliliter, adjusted for the injected FDG dose and the body weight of the patient. By averaging the maximum SUV values of all arterial slices of the left and right carotid artery and the ascending aorta a mean SUV max value was derived for all arteries.
The arterial TBR was calculated by normalizing the arterial SUV for blood-pool activity by dividing the SUV values in the arteries by the average blood mean SUV ( mean SUV mean ) estimated from both jugular veins (JV; to obtain the carotid TBR) or the superior vena cava (SVC; to obtain the aortic TBR). The TBR is a blood-normalized arterial SUV, considered to be a reflection of arterial FDG uptake and of underlying macrophage activity [22] . For evaluation of the FDG blood-pool activity, ROIs of at least six 3-4 mm were placed on consecutive slices of both JVs and the SVC and averaged.
The arterial TBR values obtained were then averaged in order to derive a mean TBR for both carotid arteries and the ascending aorta.
Statistical analysis
All continuous variables are expressed throughout as means± standard deviation and categorical data as absolute numbers and percentages. In general, the normality of data distributions was tested for all of the different statistical calculations using the Kolmogorov-Smirnov test. Depending on the normality of the distribution, continuous variables were compared using Student's t test or the Mann-Whitney U test. One-way analysis of variance (ANOVA) was used to assess the relationship between prescan glucose value tertiles and tertiles of the respective FDG circulation time for the chest and neck data acquisition as well as the injected FDG dose on the one hand and the FDG uptake parameters in the aorta and carotids on the other, with appropriate testing for multiple comparisons (to test for between-group differences). The Tukey test was used for post-hoc testing. The prescan glucose values were classified according to the recommendations of the International Diabetes Federation IGF/IGT consensus statement: normal <6.1 mmol/l (<110 mg/dl), impaired glucose tolerance ≥6.1 mmol/l (≥110 mg/dl) and <7.0 mmol/l (< 126 mg/dl), and diabetic disease ≥7.0 mmol/l (≥126 mg/dl) [23] .
Multiple regression with backward elimination and linear regression with the Enter method To investigate the relationship between each of more than one independent variable and one dependent variable, multiple regression analysis with backward elimination was used to evaluate the association between variables potentially affecting the vascular aortic and carotid FDG uptake parameters ( mean SUV max and mean TBR max ). Vascular FDG uptake parameters were treated as the response variables ( mean SUV max or mean TBR max , dependent) and the methodological, biological and demographic variables as the explanatory (independent) variables for the regression analysis. The explanatory variables included were as follows: BMI, statin medication, diabetes, oral antidiabetic medication, injected FDG dose, fasting prescan glucose levels, and FDG circulation time, i.e. the time between injection of the tracer and the start of either the chest (aortic) or the neck (carotid) data acquisition, depending on the respective response variable. For prescan fasting glucose levels, both the continuous and the classified glucose values were used in separate multivariate regression models. Following the backward analysis, the Enter regression was used to determine independent predictors of the response variables. For this method, all of the explanatory variables of the backward elimination model that showed a significant association with the FDG uptake value were retained and were entered into the regression model as a block in a single step. This entry method was preferred over the forward selection of variables since after excluding all the explanatory variables without a significant association with the different aortic and carotid wall FDG uptake values, only a few significant variables were left for a relatively low number of cases. All results of the multiregression models reported here are given with the standardized regression coefficient (β), the 95 % confidence interval, and the p value for the estimate of statistical significance.
All statistical analyses were performed using SPSS™ statistical package 16.0 (SPSS Inc.; Chicago, IL).
Results
Population characteristics
Sufficient clinical data were available for all 195 patients, and all patients were entered into the analysis (Table 1 ). In 5 of the 195 patients, the carotids could not be analyzed due to high FDG uptake in the thyroid that affected visualization and analysis of FDG uptake within the vessel. In two patients, the aortic images could not be analyzed due to poor image quality making assessment of FDG uptake within the vessel impossible. In 17 patients, no aortic scans were available for analysis as the study protocol at that time did not include aortic scans. Therefore, a total of 176 aortic scans were available for further analysis.
Image parameters
PET-related methodological data, the results of the image analyses for the ascending aorta and the common carotids and the FDG blood-pool activity in the SVC and JVare given in Table 2 . No significant differences were found in the mean SUV max values between the aorta and carotids (p = 0.261). In contrast, mean TBR max values were significantly higher in the carotids than in the aorta (p <0.0001). FDG blood-pool activity was significantly higher in the SVC than in the JV (p <0.0001; Table 2 ).
Aortic FDG uptake
The results of the multivariate regression analysis of the aortic FDG uptake are shown in Tables 3 and 4 . BMI and statin medication were positively correlated with both aortic mean SUV max and mean TBR max . FDG circulation time chest was negatively correlated with mean SUV max but was positively correlated with mean TBR max (Tables 3 and 4 ). These correlations were also seen in the ANOVA of the three different tertiles of FDG circulation time chest with significantly higher aortic mean SUV max values for the earliest tertile (≥78 -≤ 111 min between FDG injection and the start of acquisition) compared to the second tertile (>111 -<145 min; Fig. 6 , Appendix). Reflecting the positive correlation between the circulation time chest and the aortic mean TBR max values in the multivariate regression model, ANOVA revealed significantly lower mean TBR max values for the earliest tertile compared to both the second and the third tertile (≥145 min; Fig. 3 ).
The continuous prescan glucose values as well as the glucose values ≥7.0 mmol/l were negatively correlated with the mean TBR max , but showed no significant correlation with the mean SUV max values (Tables 3 and 4 ; Figs. 1 and 4; Appendix). ANOVA revealed significant differences for the aortic mean TBR max among the different groups of classified prescan glucose values with significantly lower mean TBR max values in patients with prescan glucose values ≥7.0 mmol/l compared to those with values <6.1 mmol/l (Fig. 1) .
The multivariate regression model did not show a significant correlation between the injected FDG dose and any of the aortic FDG uptake parameters (Tables 3 and 4) . Accordingly, no statistically significant differences were found for the aortic mean SUV max or the mean TBR max values for to the injected FDG dose tertiles (Figs. 2 and 5; Appendix).
Carotid FDG uptake
Continuous and classified prescan glucose values ≥7.0 mmol/l were negatively correlated with the carotid mean SUV max and mean TBR max in the multivariate regression models, but ANOVA failed to show any significant difference for either of the carotid FDG uptake parameters in relation to the three classes of prescan glucose values (Tables 5 and 6 ; Figs. 1 and 4; Appendix). In contrast, FDG circulation time neck was (Tables 5 and 6 ).
As with the aortic FDG uptake parameters, injected FDG dose failed to show any significant correlation with one of the carotid FDG uptake values in the multivariate regression models (Tables 5 and 6 ). Accordingly, no significant differences were shown for either of the carotid uptake parameters in the ANOVA of the FDG dose tertiles (Tables 5 and 6 The FDG blood-pool activity in both the SVC and the JV did not show significant differences related to the classified prescan glucose values or the injected FDG dose tertiles ( Figs. 1 and 2 ). In contrast, the FDG blood-pool activity in the SVC was significantly higher in the earliest tertile of the FDG circulation time chest compared to the two later tertiles (p <0.0001 for the second tertile p =0.002 for the third tertile). This was also the case for the first tertile of the FDG circulation time neck showing a significantly higher FDG blood activity in the JV than for the second later tertile (p =0.01; Fig. 3 ).
Discussion
FDG PET/CT is increasingly used for noninvasive imaging of vascular inflammation [1, 4-6, 10, 11, 19, 22, 24, 25] . However, standardized scan protocols to achieve the optimal image quality accompanied by the lowest possible radiation exposure for the patient and comparability between different trials from different groups are still missing. We therefore prospectively evaluated several variables, already known or suspected to potentially influence FDG uptake in target tissues including cancer or inflammation, for their impact on the vascular FDG uptake pattern. A special focus was set on the FDG circulation time, the patient's fasting prescan blood glucose levels as well as the injected FDG dose. A cross-sectional study design in a large sample population with known CVD or multiple risk factors for CVD was applied. 
FDG circulation time
The FDG circulation time is critical as a sufficient contrast between the target (plaque, arterial wall) and the background (blood) is essential to ensure proper ROI placement and thus accurate quantification of plaque FDG uptake [1, 4, [7] [8] [9] [10] [11] [12] . Therefore, a longer FDG circulation time than that for PET in oncology is advised in order to allow sufficient FDG accumulation in the arterial wall and to permit blood levels of FDG to become reduced by decay and washout. The results of the multivariate regression models showed increasing aortic and carotid mean TBR max values with increasing FDG circulation time. Whereas the circulation time did not show any effect on the mean SUV max values in the carotids, indeed at earlier acquisition times of the chest scan, mean SUV max values decreased with increasing FDG circulation time. This was also due to the FDG blood-pool activity in the SVC as well as in the JV. Most likely, this finding mainly accounts for the decreasing aortic mean SUV max values with increasing circulation times as, in contrast to the TBR values, no correction for the underlying FDG blood-pool activity is applied to SUV values. In contrast, the increasing mean TBR max values seemed more or less to reflect the increasing FDG uptake in the arterial wall only, as these values are indeed corrected for the FDG blood-pool uptake and should therefore not have been influenced by the background activity.
Our results are in line with those of previous studies showing that a circulation time for FDG in excess of 2 h gives a much higher TBR [1, 4, 10] . In order to maximize the contrast between plaque and background, other groups have used even longer times with imaging around 3 h after FDG injection [1, 4, 10] . This later time point was derived from dynamic PET studies in both patients with carotid disease and in animal models of atherosclerosis [1, 4, 10, 22] . At 1 h after injection, there is little FDG uptake with a poor plaque/background ratio. However, after 3 h the plaque/background uptake ratio becomes optimized for lesion visualization and quantification. Using this 3-h time point in an animal model that more closely mimics human atheroma, Tawakol et using PET [4] . In contrast, 1 h after injection, little FDG uptake with a poor plaque/background ratio was found. With increasing FDG circulation times, this ratio should increase due to increased specific FDG uptake into inflammatory cells and, additionally, due to decreased FDG activity within the blood pool. Our results seem to confirm an optimal acquisition time of approximately 2.5 h after injection of the tracer. At this time point, the bloodpool activity in both the SVC and the JV was lowest compared to the activity in both venous vessels at the earliest circulation time. This goes along with significantly lower mean SUV max and significantly higher mean TBR max values in the aorta in the second tertile, reflecting circulation times between 111 min and 145 min, compared to the earliest time tertile. An optimal acquisition time of 2.5 h as seen in our study is further supported by the study of Tawakol et al. in which an acquisition time of 3 h was used that still led to excellent correlations between FDG uptake and histology [4] . This indeed argues against a relevant cellular FDG washout in the target tissue. Starting data acquisition as early as 60 min after FDG injection, as recommended by some, seems not to be appropriate as, based on our results, blood-pool activity was highest and mean TBR max values lowest during the earliest circulation time tertile which, for the chest scan, starts even later at 60 min with times of about 78 min after injection [7, 26] . In contrast, prolonging the circulation time to above 145 min did not lead to a further relevant improvement in aortic FDG uptake, even though the mean TBR max values were significantly higher for the third compared to the second time tertile. At longer FDG circulation times, as generally seen for the neck (carotid) scan in our study, the impact of the circulation time seems of less relevance as no significant differences among the three FDG circulation time neck tertiles were found for either the mean SUV max or the mean TBR max values in the carotids.
Prescan fasting glucose values
Previous studies strongly suggest an impact of a patient's prescan glucose levels on FDG uptake at least in oncological imaging [13, 15, 16] . The observed reduction in FDG uptake is most likely due to competition between glucose and FDG as facilitative transport via the glucose transporter protein (GLUT) system is the most important way for either glucose or FDG to enter human cells [27] . Additionally, it has been shown that uptake of FDG in macrophages in culture depends not only on the culture duration and the degree of macrophage activation but also on the prevailing glucose concentration which is associated with a decreasing FDG uptake with increases in the glucose load in the culture medium [28] . As diabetes is strongly associated with atherosclerotic disease, the problem of elevated prescan glucose levels occurs frequently in patients scheduled for FDG PET imaging of vessel wall inflammation. The impact of glucose on FDG uptake in inflammatory lesions is less well investigated. Cell culture experiments suggest that moderate hyperglycemia (up to 250 mg/dl, 14 mmol/l) does not adversely affect FDG uptake in inflammatory cells [14] . In contrast, data from experimental studies in rats not only showed a significantly reduced FDG uptake in the lesions of infectious and noninfectious inflammatory models with moderate hyperglycemia (150-180 mg/dl, 8.3-10.0 mmol/l) but also decreased GLUT-1 and GLUT-3 levels on glucose loading in lesions of infectious origin [29, 30] . Therefore, the reproducibility of atheroma imaging with FDG might be expected to be worse in those with high blood sugar at the time of imaging compared with normoglycemic subjects. Our data support this. We found a negative association between prescan glucose levels on FDG uptake in the aorta and carotid arteries in terms of mean TBR max and also in terms of mean SUV max values in the carotids. In contrast, we observed increased FDG blood-pool activity in the SVC with increased prescan glucose values. As the FDG activity in the SVC is used to calculate aortic TBRs this finding might at least partly explain the lower TBRs in patients with high prescan glucose values. Furthermore, the results of the present study also seem to confirm that even moderate hyperglycemia lowers FDG uptake into inflammatory cells, as we found prescan glucose levels at any level higher than 7.0 mmol/l to be negatively associated with vascular FDG uptake. Glucose values below that level failed to have any impact on FDG accumulation. Patients with prescan glucose levels higher than 7.0 mmol/l should therefore be excluded from vascular FDG imaging studies if possible or, if not and also in the clinical setting, data analysis should be performed using an appropriate mathematical glucose correction for vascular FDG uptake [31] .
Injected FDG dose
The injected FDG dose had no significant impact on any of the vascular FDG uptake parameters and there were no significant differences in the vascular FDG uptake in relation to the different injected dose tertiles. Therefore, injection of a rather small FDG dose of between 307 and 458 MBq seems to be justified. This dose seems applicable even in over-weight patients, as in the multivariate regression model, injected FDG dose was adjusted for BMI, and BMI values failed to show a negative association with vascular FDG uptake. Indeed, a significantly positive association between BMI and arterial and blood-pool FDG uptake was seen. This finding is important with regard to radiation protection issues for patients, mainly as an increasing number of clinical trials with one or more followup PET scans requested have to be expected more frequently in the future [24, 25] . This might have been expected, as we note that some studies have successfully used doses of FDG as low as 185 MBq without undue degradation of either image quality or lesion quantification [10] .
FDG uptake parameters
Our results are highly consistent for the two applied FDG uptake parameters except for the impact of shorter FDG circulation times on aortic FDG uptake. As we performed the chest scan first in the current trial, compared to the neck scan, shorter circulation times had a negative association with aortic mean SUV max but a positive impact on mean TBR max values. This is most likely due to increased FDG blood activity at this time for which the mean SUV max values are not corrected. The impact of mainly the shorter circulation times on vascular FDG uptake is confirmed by the fact that at the later acquisition times for the neck scans, no significant association with the carotid mean SUV max values was observed at all. We also found significantly higher carotid mean TBR max values as compared to the respective aortic FDG uptake parameter, which might also be related to the longer circulation time for the neck data acquisition leading to a lower impact of FDG blood-pool activity on arterial 
Limitations
In the present study images were analyzed by only one reader. This might have reduced statistical noise related to interobserver variation but might raise concerns regarding intraobserver bias.
However, previous studies have demonstrated that this method has good inter-and intraobserver reproducibility [19, 21] . As we did not use contrast-enhanced CT, soft plaques in the vessels could not be detected. We used CT without contrast enhancement so that those with renal impairment could be imaged. However, we intentionally chose a population either with defined atherosclerosis (e.g. known CAD, carotid artery disease, etc.) or multiple risk factors for atherosclerosis, and we included all evaluable slices of the arterial wall. Thus, both focal and diffuse areas of FDG uptake were included in the analysis.
Furthermore, subjects with known vasculitis were excluded, and we assumed that any FDG signal within the vessel wall was likely to be due to accumulation of the tracer within atherosclerotic plaque. Others have previously demonstrated colocalization between lipid-rich plaque and FDG uptake [32] .
Finally, some of the correlations we found were modest. However, being statistically significant they still provide important and relevant insights about factors impacting vascular FDG uptake, which need to be taken into account in future prospective trials using dedicated vascular PET imaging protocols.
Conclusion
FDG circulation time and prescan fasting glucose values may affect vascular FDG uptake. This has to be taken into account when designing FDG PET protocols. FDG circulation times of about 2.5 h are preferred and prescan glucose values ≥7.0 mmol/ l should be avoided. An FDG dose of between 307 and 458 MBq seems to be justified to achieve an appropriate scan quality and is likely to be optimal for repeated scans in clinical 
